ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,787, issued on Sept. 22, was assigned to BG Medicine Inc. (Waltham, Mass.).
"Galectin-3 immunoassay" was invented by Pieter Muntendam (Boxford, Mass.) and Shunguang Wang (Carlisle, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods and compositions for specifically and quantitatively detecting galectin-3 in a sample. Embodiments of the invention include a detection assay in which a capture binding moiety and a labeled binding moiety specifically recognize non-overlapping epitopes on the N-terminus of galectin-3. Further embodiments are directed to a method for establishing ranges of galectin-3 concentratio...